These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 1689123)

  • 41. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE; Hiroshima K; Marchevsky AM
    Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features: a clinicopathologic study of 22 cases.
    Moran CA; Suster S
    Mod Pathol; 2000 May; 13(5):489-94. PubMed ID: 10824919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of sarcomatoid carcinoma of the thymus.
    Nishimura M; Kodama T; Nishiyama H; Nishiwaki Y; Yokose T; Shimosato Y
    Pathol Int; 1997 Apr; 47(4):260-3. PubMed ID: 9103218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm.
    Suster S; Moran CA
    Am J Surg Pathol; 1999 Jun; 23(6):691-700. PubMed ID: 10366152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases.
    Banks ER; Frierson HF; Mills SE; George E; Zarbo RJ; Swanson PE
    Am J Surg Pathol; 1992 Oct; 16(10):939-46. PubMed ID: 1384369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and immunohistochemical study of eight cases with thymic carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
    BMC Surg; 2002 May; 2():3. PubMed ID: 12049674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
    Kojika M; Ishii G; Yoshida J; Nishimura M; Hishida T; Ota SJ; Murata Y; Nagai K; Ochiai A
    Mod Pathol; 2009 Oct; 22(10):1341-50. PubMed ID: 19648882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinicopathologic assessment of primary thymic carcinoma based on seven cases].
    Fujimura S; Kondo T; Handa M; Ichinose T; Shiraishi Y; Matsumura Y; Sasaki H; Kumagai M; Okada K; Nakada T
    Kyobu Geka; 1989 Feb; 42(2):86-96. PubMed ID: 2733296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus: Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Suster D; Pihan G; Mackinnon AC; Suster S
    Am J Surg Pathol; 2018 Sep; 42(9):1224-1236. PubMed ID: 29975245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathologic diagnoses of core needle biopsies of the mediastinum].
    Liu M; Hou N; Song X; Yu DJ; Zhao P; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):135-9. PubMed ID: 15132850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thymic carcinoma. Report of five cases and review of the literature.
    Hartmann CA; Roth C; Minck C; Niedobitek G
    J Cancer Res Clin Oncol; 1990; 116(1):69-82. PubMed ID: 2179229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucoepidermoid carcinoma of uterine cervix stage IB. Long-term follow-up, histochemical and immunohistochemical study.
    Thelmo WL; Nicastri AD; Fruchter R; Spring H; DiMaio T; Boyce J
    Int J Gynecol Pathol; 1990; 9(4):316-24. PubMed ID: 1700969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B-cell antigen marker expression in nasopharyngeal carcinoma.
    Zhong XY; Senba M; Gu JN; Itakura H
    Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients.
    Wong TY; Suster S; Nogita T; Duncan LM; Dickersin RG; Mihm MC
    Cancer; 1994 Mar; 73(6):1631-43. PubMed ID: 7512435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
    Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinicopathologic study of thymic epithelial tumors].
    Adachi K; Hosaka N; Takao M; Fujinaga K
    Kyobu Geka; 2005 Feb; 58(2):119-22. PubMed ID: 15724473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
    Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
    Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.